Table 3.
Relationship between CASC2a expression and clinicopathological features of UCUB.
| CASC2a expression | t/χ2/Z | P | ||
|---|---|---|---|---|
| Low (n=56) | High (n=56) | |||
| Gender | ||||
| Male | 42 | 47 | ||
| Female | 14 | 9 | 1.368 | 0.242 |
| pT classification | ||||
| pT0–1 | 11 | 25 | ||
| pT2 | 15 | 13 | ||
| pT3 | 20 | 15 | ||
| pT4 | 10 | 3 | 3.017 | 0.003 |
| pN classification | ||||
| pN0 | 37 | 48 | ||
| pN+ | 19 | 8 | 5.905 | 0.015 |
| Tumor grade | ||||
| Low grade (grade 1, 2) | 7 | 2 | ||
| High grade (grade 3) | 49 | 54 | 3.020 | 0.082 |
| Tumor size | ||||
| <3 cm | 46 | 54 | ||
| ≥3 cm | 10 | 2 | 5.973 | 0.015 |
| Concomitant CIS | ||||
| Absent | 28 | 33 | ||
| Present | 28 | 23 | 0.900 | 0.343 |
| LVI | ||||
| Absent | 31 | 45 | ||
| Present | 25 | 11 | 8.023 | 0.005 |
| STSM | ||||
| Negative | 52 | 54 | ||
| Positive | 4 | 2 | 0.704 | 0.401 |
| Adjuvant chemotherapy | ||||
| No | 42 | 47 | ||
| Yes | 14 | 9 | 1.368 | 0.242 |